Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,187 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06249282RecruitingPhase 1
Carfilzomib and sotorasib for KRAS G12C lung cancer
This trial tests a combination of two drugs: carfilzomib and sotorasib, for people with a specific type of advanced lung cancer (KRAS G12C mutation) who have already tried a KRAS-targeting drug that stopped working. The goal is to see if this new combination can shrink tumors or slow the cancer.
Duarte, CaliforniaAges 18 years+ - NCT06229717Recruiting
Balance and hearing study for children with hearing loss
This study looks at how hearing loss affects balance in children aged 3 to 10. It tests balance and inner ear function to help understand the connection between hearing and balance problems.
HerningAges 3–10 - NCT06229730Recruiting
Normal balance and hearing in Danish children
This study measures normal balance and inner ear function in healthy children aged 6 months to 10 years. It helps doctors understand what is typical for kids, which can improve care for those with balance issues.
HerningAges 6 months–10 years - NCT06251778Recruiting
National study of ATTR heart amyloid patients on tafamidis
This study follows patients with a specific type of heart amyloidosis (wild-type ATTR) who are taking or could start the drug tafamidis. It aims to learn more about how the condition and treatment affect people over time.
PaviaAges 18–99 - NCT06249672Recruiting
Long-term outcomes after rectal preservation for rectal cancer
This study looks at how well people with rectal cancer do over time when they try to keep their rectum instead of having surgery. It is for patients who have already had chemoradiation and whose tumor has shrunk to a small scar (2 cm or less).
BernAges 18 years+ - NCT06249412Recruiting
Positive pressure breathing device for ALS patients
This trial tests whether a mask that helps you breathe out (positive expiratory pressure) combined with a cough-assist machine (in-exsufflator) improves breathing and coughing in people with ALS who have bulbar symptoms like trouble speaking, swallowing, or drooling.
Le Havre, NormandyAges 18–100 - NCT06249867RecruitingPhase 2
Study of darifenacin for people with ALS
This trial tests a medication called darifenacin (usually used for bladder problems) in people with ALS, to see if it is safe and if it might help slow the disease. If you join, you will take the study drug or a placebo and be closely monitored.
Ottawa, OntarioAges 18–85 - NCT06244953Recruiting
Heart failure support program with palliative care
This study tests whether a tailored program that includes palliative care (extra support for comfort and quality of life) can help people with advanced heart failure and their family caregivers. It aims to reduce hospital visits and improve well-being.
SingaporeAges 21–99 - NCT06241677Recruiting
Clot-busting therapy for stroke patients on blood thinners
This study tests whether giving a clot-busting medicine through an IV can help people who have had a stroke while taking a common blood thinner (apixaban, dabigatran, edoxaban, or rivaroxaban). It may be an option if your last dose of the blood thinner was 12 to 48 hours before the stroke and you arrive at the hospital within 4.5 hours of symptoms starting.
Hong KongAges 18 years+ - NCT06240195Recruiting
Study of sacituzumab govitecan for advanced triple-negative breast cancer
This study is testing a drug called sacituzumab govitecan (SG) for people with advanced triple-negative breast cancer who have already had other treatments. The goal is to see how well the drug works and what side effects it causes, using your tumor samples to look for clues (biomarkers).
Rome, RomeAges 18 years+ - NCT06245603Recruiting
Testing Hydeal Cyst with standard treatment for bladder cancer
This study tests a bladder instillation called Hydeal Cyst, given alongside standard BCG or MMC therapy, to see if it helps reduce side effects or improve outcomes for people with non-muscle invasive bladder cancer.
BergamoAges 18 years+ - NCT06239974Recruiting
Vericiguat for chest pain from small vessel heart disease
This study tests whether a medication called vericiguat can improve chest pain caused by problems in the tiny blood vessels of the heart (not by large blockages). You may be a candidate if you have stable chest pain, are 40–75, and have had tests showing your heart's small vessels aren't working well.
Hong KongAges 40–75 - NCT06229704Recruiting
Balance and dizziness study for children aged 6 months to 10 years
This study tests balance and inner-ear function in children who have delays in gross motor skills or dizziness/balance problems. It aims to understand these issues better and may help guide future care.
HerningAges 6 months–10 years - NCT06251713Recruiting
Fluid removal guided by VeXUS score after heart surgery
This trial tests if using a special ultrasound score (VeXUS) to guide fluid removal can improve recovery in patients with acute kidney injury after heart surgery. It compares this approach to standard care to see if it leads to better outcomes.
Bron, BronAges 18–85 - NCT06247449Recruiting
MRI screening for brain metastases in aggressive breast cancer
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
Toronto, OntarioAges 18 years+ - NCT06250309Recruiting
Mediterranean diet vs. Western diet for fatigue in AIH
This study tests whether a Mediterranean diet can reduce fatigue in people with autoimmune hepatitis (AIH) compared to a typical Western diet. You will receive frozen meals for a week and track your energy levels.
Indianapolis, IndianaAges 18–80 - NCT06238882Recruiting
Nitroglycerin plus radiation for EGFR-mutant lung cancer with brain spread
This trial tests whether adding nitroglycerin (a medicine that widens blood vessels) to standard whole-brain radiation helps improve treatment for lung cancer that has spread to the brain. It is for people with a specific gene change (EGFR mutation) in their cancer.
Mexico City, Mexico CityAges 18–85 - NCT06229990RecruitingPhase 4
Using furosemide stress test to stop kidney replacement therapy
This study tests whether a furosemide (a water pill) stress test can help doctors decide when to safely stop continuous kidney replacement therapy in ICU patients with severe acute kidney injury. It may allow you to come off the machine sooner if your kidneys respond well.
Chiang MaiAges 20 years+ - NCT06230341Recruiting
Safety incidents in primary care teams
This study looks at how patient safety problems happen in coordinated primary care teams (called MSPs) in the Pays de la Loire region of France. It aims to understand and improve safety for patients and staff.
Nantes, FranceAges Any age - NCT06234410Recruiting
Heart risk check before kidney transplant
This study uses a special heart CT scan (called coronary angiography) to check the heart health of people waiting for a kidney transplant. It aims to see if this scan can help doctors better assess and manage heart risks before surgery.
Edinburgh, LothianAges 16 years+ - NCT06247189Recruiting
ICOPE program for older adults with myeloma
This trial tests whether a program called ICOPE MONITOR, which uses a smartphone app or chatbot, can help older adults with multiple myeloma stay healthier and manage their care. It may be a good fit if you are 70+ and starting your first or second treatment.
ToulouseAges 70 years+ - NCT06249191RecruitingPhase 1/Phase 2
Mosunetuzumab plus chemo for untreated high-grade B-cell lymphoma
This trial tests adding a drug called mosunetuzumab to standard chemotherapy for people with certain aggressive B-cell lymphomas. It aims to see if the combination works better than chemo alone.
Portland, OregonAges 18–75 - NCT06236139RecruitingPhase 1/Phase 2
Immune cells plus hormone therapy for advanced prostate cancer
This study tests a new type of treatment that uses your own immune cells (engineered to target prostate cancer) combined with a hormone therapy drug. It is for men with advanced prostate cancer that has stopped responding to standard hormone treatments.
Seattle, WashingtonAges 18 years+ - NCT06236724RecruitingPhase 2
Asciminib for newly diagnosed chronic myeloid leukemia
This study tests a targeted pill called asciminib for people newly diagnosed with chronic-phase CML. It aims to see if this drug is safe and effective as an early treatment option.
Houston, TexasAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,187 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.